Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODM-108 single- and multiple-ascending-dose study in healthy male volunteers
NL-OMON42514Active, not recruiting
- Sponsor
- Orion Corporation
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of ODM-108 in Neuralgia (2 arms), sponsored by Orion Corporation. Started Apr 2015; status: active, not recruiting.
02
Drugs
ODM-108
03
Conditions
Neuralgia
Beyond the preview
Go deeper on NL-OMON42514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42514.